CLARITAS RX

Serial Number 98125249
Registration 7594009
700

Registration Progress

Application Filed
Aug 9, 2023
Under Examination
Approved for Publication
Oct 8, 2024
Published for Opposition
Oct 8, 2024
Registered
Dec 10, 2024

Trademark Image

CLARITAS RX

Basic Information

Serial Number
98125249
Registration Number
7594009
Filing Date
August 9, 2023
Registration Date
December 10, 2024
Published for Opposition
October 8, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 10, 2024
Registration
Registered
Classes
042

Rights Holder

CLARITAS RX INC.

03
Address
400 Oyster Point Boulevard, Suite 329
South San Francisco, CA 94080

Ownership History

CLARITAS RX INC.

Original Applicant
03
South San Francisco, CA

CLARITAS RX INC.

Owner at Publication
03
South San Francisco, CA

CLARITAS RX INC.

Original Registrant
03
South San Francisco, CA

Legal Representation

Attorney
R. Lee Fraley

USPTO Deadlines

Next Deadline
1960 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-12-10)
Due Date
December 10, 2030
Grace Period Ends
June 10, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

23 events
Date Code Type Description Documents
Dec 10, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 10, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 8, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 8, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 18, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 29, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 29, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 29, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 29, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Aug 29, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 15, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 15, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 15, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 22, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 21, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 21, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 10, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 10, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 10, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 9, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 12, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 10, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 12, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Software as a service (SAAS) services featuring software to aggregate and process data, generate and share information and reports in the field of pharmaceuticals, and provide advanced predictive analytics to support patient accessibility to pharmaceuticals, pharmaceutical contracting, patient services insights, and medication payer insights, and commercial operations for pharmaceutical companies for use in developing strategies for commercialization of products and services within the field of biopharmaceuticals
First Use Anywhere: 20190500
First Use in Commerce: 20190500

Additional Information

Design Mark
The mark consists of the wording "CLARITAS RX" with the letter "C" and "R" capitalized; to the left of the wording appears a stylized image of a diamond.
Color Claim
Color is not claimed as a feature of the mark.
Other
as to "RX" has become distinctive of the goods/services through the applicant's substantially exclusive and continuous use of the mark in commerce that the U.S. Congress may lawfully regulate for at least the five years immediately before the date of this statement.

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"RX"